260 related articles for article (PubMed ID: 15880983)
1. Ocular complications after a sub-tenon injection of triamcinolone acetonide for uveitis.
Kuo HK; Lai IC; Fang PC; Teng MC
Chang Gung Med J; 2005 Feb; 28(2):85-9. PubMed ID: 15880983
[TBL] [Abstract][Full Text] [Related]
2. The effect of intravitreal triamcinolone on intraocular pressure.
Kramar M; Vu L; Whitson JT; He YG
Curr Med Res Opin; 2007 Jun; 23(6):1253-8. PubMed ID: 17559723
[TBL] [Abstract][Full Text] [Related]
3. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
Sallam A; Sheth HG; Habot-Wilner Z; Lightman S
Am J Ophthalmol; 2009 Aug; 148(2):207-213.e1. PubMed ID: 19403113
[TBL] [Abstract][Full Text] [Related]
4. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
Roth DB; Verma V; Realini T; Prenner JL; Feuer WJ; Fechtner RD
Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
[TBL] [Abstract][Full Text] [Related]
5. Trabeculectomy with or without intraoperative sub-tenon injection of triamcinolone acetonide in treating secondary glaucoma.
Yuki K; Shiba D; Kimura I; Ohtake Y; Tsubota K
Am J Ophthalmol; 2009 Jun; 147(6):1055-60, 1060.e1-2. PubMed ID: 19327739
[TBL] [Abstract][Full Text] [Related]
6. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
[TBL] [Abstract][Full Text] [Related]
7. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
Chieh JJ; Carlson AN; Jaffe GJ
Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
[TBL] [Abstract][Full Text] [Related]
8. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection.
Iwao K; Inatani M; Kawaji T; Koga T; Mawatari Y; Tanihara H
J Glaucoma; 2007 Mar; 16(2):251-6. PubMed ID: 17473740
[TBL] [Abstract][Full Text] [Related]
9. Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis.
Bollinger K; Kim J; Lowder CY; Kaiser PK; Smith SD
Ophthalmology; 2011 Oct; 118(10):1927-31. PubMed ID: 21652079
[TBL] [Abstract][Full Text] [Related]
10. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection.
Yamamoto Y; Komatsu T; Koura Y; Nishino K; Fukushima A; Ueno H
Can J Ophthalmol; 2008 Feb; 43(1):42-7. PubMed ID: 18204501
[TBL] [Abstract][Full Text] [Related]
11. Outcome of intravitreal triamcinolone in uveitis.
Kok H; Lau C; Maycock N; McCluskey P; Lightman S
Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
13. Adverse events after intravitreal triamcinolone in patients with and without uveitis.
Galor A; Margolis R; Brasil OM; Perez VL; Kaiser PK; Sears JE; Lowder CY; Smith SD
Ophthalmology; 2007 Oct; 114(10):1912-8. PubMed ID: 17908594
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide and intraocular pressure.
Smithen LM; Ober MD; Maranan L; Spaide RF
Am J Ophthalmol; 2004 Nov; 138(5):740-3. PubMed ID: 15531307
[TBL] [Abstract][Full Text] [Related]
15. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
Inatani M; Iwao K; Kawaji T; Hirano Y; Ogura Y; Hirooka K; Shiraga F; Nakanishi Y; Yamamoto H; Negi A; Shimonagano Y; Sakamoto T; Shima C; Matsumura M; Tanihara H
Am J Ophthalmol; 2008 Apr; 145(4):676-681. PubMed ID: 18243153
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
[TBL] [Abstract][Full Text] [Related]
17. Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery.
Kim SY; Yang J; Lee YC; Park YH
J Cataract Refract Surg; 2008 May; 34(5):823-6. PubMed ID: 18471640
[TBL] [Abstract][Full Text] [Related]
18. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
20. Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.
Hirano Y; Ito T; Nozaki M; Yasukawa T; Sakurai E; Yoshida M; Ogura Y
Jpn J Ophthalmol; 2009 Sep; 53(5):519-22. PubMed ID: 19847609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
